In Queue For Vaccine
Although the reputation of Wall Street financiers might have been perceived as strikingly negative, the recent phenomena proved they are still privileged. The leading finance companies: Goldman Sachs, Citigroup and Morgan Stanley were first to obtain exceedingly desirable H1N1 vaccine for employees. The occurrence initiated turmoil, a spate of criticism and complaints was prompted. The opponents claim that the government should not be biased in the case of a swine influenza plague. On the other hand the bankers assure everyone that they have received adequate amount of antidote only due to the fact that they ordered it early enough. It is also stated that the medicine will be administered only in severe cases. Nevertheless, it is claimed that in the face of influenza pandemic no exceptions should be made mainly because influenza vaccine is inadequate.
An article “Wall Street bankers at front of queue for scarce swine flu vaccine”
http://www.guardian.co.uk/business/2009/nov/06/wall-street-bankers-swine-flue